1 year target of Retrophin, Inc.
One year target is an estimate of a stock price for a point in time equal to a year from the current date. The price level most often reflects the collective opinion of different analysts on where the stock will be trading a year from now. For an analyst to identify an individual estimate, they have to project what a company’s business will look like in a year, typically focusing on revenue and other significant factors. They also consider the willingness of investors to pay a certain price. While the average or median recommendation may be predictive and reflect the actual future value, the results are usually not extremely successful.
Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; Cholbam, a cholic acid capsule to treat pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects, and for adjunctive treatment of patients with peroxisomal disorders; and Thiola, a tiopronin tablet for the treatment of cystinuria. The company's product candidates consist of Sparsentan, which is in Phase III clinical trial for the treatment of focal segmental glomerulosclerosis; Fosmetpantotenate, a novel small molecule that is in Phase III clinical trial to treat pantothenate kinase-associated neurodegeneration; Tetracosactide Zinc (RE-034), a synthetic hormone analog that is in preclinical stage; and Liquid Ursodeoxycholic Acid, a liquid formulation of ursodeoxycholic acid, which is in preclinical stage to treat primary biliary cholangitis. Retrophin, Inc. was founded in 2011 and is headquartered in San Diego, California.
|YGYI Youngevity International, Inc.||NASDAQ > Consumer Services > Catalog/Specialty Distribution||-41.12|
|LOOP Loop Industries, Inc.||NASDAQ||-41.01|
|CDZI Cadiz, Inc.||NASDAQ > Public Utilities > Water Supply||-41.00|
|QRHC Quest Resource Holding Corporation.||NASDAQ > Technology > Diversified Commercial Services||-40.64|
|WTT Wireless Telecom Group, Inc.||NYSEMKT > Capital Goods > Electrical Products||-40.36|
|HZNP Horizon Pharma plc||NASDAQ > Health Care > Major Pharmaceuticals||-39.47|
|RTRX Retrophin, Inc.||NASDAQ > Health Care > Major Pharmaceuticals||-39.05|
|RDWR Radware Ltd.||NASDAQ > Miscellaneous > Business Services||908.53|
|NOW ServiceNow, Inc.||NYSE > Technology > Computer Software: Prepackaged Software||2,096.84|
|XTNT Xtant Medical Holdings, Inc.||NYSEMKT > Health Care > Biotechnology: Biological Products (No Diagnostic Substances)||2,385.30|
|FET Forum Energy Technologies, Inc.||NYSE > Energy > Metal Fabrications||8,053.25|
|CALD Callidus Software, Inc.||NASDAQ > Technology > EDP Services||14,180.27|
|TSLA Tesla, Inc.||NASDAQ > Capital Goods > Auto Manufacturing||16,068.78|